Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.64 SEK | -0.62% | +1.91% | -47.97% |
Apr. 16 | Nanexa AB Announces Approval of Clinical Trial Application for NEX-22 Study Delayed | CI |
Mar. 08 | Transcript : Nanexa AB - Special Call |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB